Table 6.

Cox regression analysis for risks of mid-term mortality.

Variable	Univariate analysis			Multivariate analysis
	p	Hazard ratio	95% CI	p	Hazard ratio	95% CI
Age	0.528	1.011	0.977–1.046
Sex	0.859	1.083	0.448–2.618
CONUT score	<0.001	1.53	1.304–1.796	0.027	1.276	1.029–1.584
Present with symptoms	0.182	1.605	0.802–3.213
Hypertension	0.279	0.646	0.292–1.427
DM	0.847	0.921	0.401–2.116
Dyslipidemia	0.081	0.518	0.248–1.084
Stroke	0.201	1.677	0.759–3.705
Renal dysfunction	0.128	1.693	0.860–3.333
Respiratory diseases	0.03	0.416	0.188–0.920	0.062	0.396	0.150–1.048
Digestive system diseases	0.068	0.461	0.201–1.058
CAD	0.674	0.827	0.343–1.998
Prior peripheral artery disease	0.447	1.499	0.528–4.255
Current smoker	0.333	0.567	0.180–1.787
Methods of anesthesia	0.853	0.938	0.476–1.846
AAA diameter	0.939	0.988	0.729–1.339
Diameter of the proximal aneurysmal neck	0.859	1.096	0.399–3.006
Length of aneurysmal neck	0.586	0.939	0.748–1.179
Distorted aneurysmal neck	0.244	0.636	0.298–1.360
Calcified aneurysmal neck	0.982	1.009	0.472–2.157
Mural thrombus	0.482	1.296	0.629–2.671
Types of stents	0.007	2.84	1.325–6.087	0.063	2.36	0.954–5.839
WBC	0.414	1.068	0.912–1.252
Hb	<0.001	0.97	0.957–0.984	0.113	0.984	0.965–1.004
Plt	0.203	1.003	0.998–1.008
CRP	0.001	1.01	1.004–1.015	0.221	1.006	0.997–1.015
Cr	0.11	1.001	1.000–1.002
eGFR	0.671	0.998	0.987–1.008
PT	<0.001	1.334	1.171–1.520	0.474	1.077	0.880–1.317
Fibrinogen	0.03	1.378	1.032–1.839	0.91	0.978	0.661–1.446
D-dimer	0.52	1.023	0.954–1.098

AAA, abdominal aortic aneurysm; CAD, coronary artery disease; CONUT, controlling nutritional status; Cr, creatinine; DBP, diastolic blood pressure; DM, diabetes mellitus; Hb, hemoglobin; Plt, platelet; SBP, systolic blood pressure; WBC, white blood cell. The bold values represent a statistical difference between the two groups.